Back to Search Start Over

Impact of point‐of‐care HIV viral load and targeted drug resistance mutation testing on viral suppression among Kenyan pregnant and postpartum women: results from a prospective cohort study (Opt4Mamas)

Authors :
Rena C. Patel
Patrick Oyaro
Katherine K. Thomas
Garoma Wakjira Basha
James Wagude
Irene Mukui
Evelyn Brown
Shukri A. Hassan
Eunice Kinywa
Fredrick Oluoch
Francesca Odhiambo
Boaz Oyaro
Leonard Kingwara
Enericah Karauki
Nashon Yongo
Lindah Otieno
Grace C. John‐Stewart
Lisa L. Abuogi
Source :
Journal of the International AIDS Society, Vol 26, Iss 11, Pp n/a-n/a (2023)
Publication Year :
2023
Publisher :
Wiley, 2023.

Abstract

Abstract Introduction Lack of viral suppression (VS) among pregnant and breastfeeding women living with HIV poses challenges for maternal and infant health, and viral load (VL) monitoring via centralized laboratory systems faces many barriers. We aimed to determine the impact of point‐of‐care (POC) VL and targeted drug resistance mutation (DRM) testing in improving VS among pregnant and postpartum women on antiretroviral therapy. Methods We conducted a pre/post‐intervention prospective cohort study among 820 pregnant women accessing HIV care at five public‐sector facilities in western Kenya from 2019 to 2022. The pre‐intervention or “control” group consisted of standard‐of‐care (SOC) centralized VL testing every 6 months and the post‐intervention or “intervention” group consisted of a combined strategy of POC VL every 3 months, targeted DRM testing, and clinical management support. The primary outcome was VS (VL ≤1000 copies/ml) at 6 months postpartum; secondary outcomes included uptake and turnaround times for VL testing and sustained VS. Results At 6 months postpartum, 321/328 (98%) of participants in the intervention group and 339/347 (98%) in the control group achieved VS (aRR 1.00, 95% confidence interval [CI] 0.98, 1.02). When assessing VS using a threshold of 1000 copies/ml) who underwent successful DRM testing in the intervention group, all (46/46, 100%) had some DRMs and 20 (43%) had major DRMs (of which 80% were nucleos(t)ide reverse transcriptase inhibitor mutations). POC VL testing uptake was high (>89%) throughout pregnancy, delivery, and postpartum periods, with a median turnaround time of 1 day (IQR 1, 4) for POC VL in the intervention group and 7 days (IQR 5, 9) for SOC VL in the control group. Sustained VS throughout follow‐up was similar between groups with either POC or SOC VL testing (90−91% for

Details

Language :
English
ISSN :
17582652
Volume :
26
Issue :
11
Database :
Directory of Open Access Journals
Journal :
Journal of the International AIDS Society
Publication Type :
Academic Journal
Accession number :
edsdoj.4084644bb4ad4c6bba6b60a01d52eff1
Document Type :
article
Full Text :
https://doi.org/10.1002/jia2.26182